Improved Pharma and Excelsus Structural Solutions (Swiss) AG are continuing their collaboration to better enable access to synchrotron facilities for industrial clients, especially for pharmaceutical R&D.  At the conference, we discussed recent scientific advances, provided instruction on XRPD and pairwise distribution function (PDF) analysis, and facilitated discussions focused on establishing guidelines for the analysis of Read more

May is speed month here in Indiana, home of the Indy 500.  Improved Pharma is celebrating speed month by highlighting services that help you speed your drug development and reduce time to market.  Importantly, it is Improved Pharma’s expertise and scientific knowledge that is the key to faster, cheaper drug development.  We have a range Read more

Award honorees have made significant contributions to pharmaceutical sciences that promote public health ARLINGTON, VA (SEPTEMBER 21, 2018) The American Association of Pharmaceutical Scientists (AAPS) is proud to announce the winners of four of its global leadership awards: Pharmaceutical Global Health, Emerging Leader, AAPS Foundation Graduate Fellowships, and Student Chapter of the Year. Recognizing leaders Read more

Improved Pharma, LLC is also proud to announce a collaboration with Excelsus Structural Solutions (ESS, Switzerland) to provide services related to Synchrotron X-ray diffraction for both amorphous and crystalline materials. The combination of Prof. Byrn's expertise in structural characterization of amorphous pharmaceuticals via total scattering, spectroscopic and thermal techniques, with recent advances by ESS Read more

Professor Simon Billinge of Columbia University and Improved Pharma have established a collaboration agreement to provide Synchrotron services to the pharmaceutical industry and pharmaceutical developers in a seamless manner. This collaboration will greatly simplify business linkages to Professor Billinge’s program. In many cases Improved Pharma will collect data at Professor Billinge’s direction and he will Read more

Dr. Pamela A. (Martoglio) Smith has joined Improved Pharma as COO. Dr. Smith was most recently Vice President of Analytical Services for AMRI, where she was responsible for 300 employees at four global sites. One of those sites included SSCI, the cGMP contract research organization founded by Dr. Steve Byrn and Sally Byrn. She has Read more